Most cited documents in this series:

Year	Title	Cited
2006	The relationship between health care expenditure and health outcomes RePEc:spr:eujhec:v:7:y:2006:i:1:p:7-18 [Citation Analysis]	12
2003	Economic burden of obesity and its complications in Germany RePEc:spr:eujhec:v:4:y:2003:i:4:p:248-253 [Citation Analysis]	6
2007	Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set RePEc:spr:eujhec:v:8:y:2007:i:1:p:31-39 [Citation Analysis]	5
2007	Risk adjustment policy options for casemix funding: international lessons in financing reform RePEc:spr:eujhec:v:8:y:2007:i:3:p:195-212 [Citation Analysis]	5
2005	Spatial competition for quality in the market for hospital care RePEc:spr:eujhec:v:6:y:2005:i:2:p:131-135 [Citation Analysis]	5
2006	Price regulation and generic competition in the pharmaceutical market RePEc:spr:eujhec:v:7:y:2006:i:3:p:204-211 [Citation Analysis]	5
2004	An empirical analysis of the demand for physician services across the European Union RePEc:spr:eujhec:v:5:y:2004:i:2:p:150-165 [Citation Analysis]	4
2007	Economic aspects of the new Spanish laws on pharmaceutical preparations RePEc:spr:eujhec:v:8:y:2007:i:3:p:297-300 [Citation Analysis]	4
2005	An empirical analysis of tobacco addiction in Italy RePEc:spr:eujhec:v:6:y:2005:i:3:p:233-243 [Citation Analysis]	4
2004	Measuring and comparing the (in)efficiency of German and Swiss hospitals RePEc:spr:eujhec:v:5:y:2004:i:3:p:216-226 [Citation Analysis]	4
2003	Should one use smokeless tobacco in smoking cessation programs? RePEc:spr:eujhec:v:4:y:2003:i:4:p:263-270 [Citation Analysis]	3
2004	Economic evidence in multiple sclerosis: a review RePEc:spr:eujhec:v:5:y:2004:i:1:p:s54-s62 [Citation Analysis]	3
2005	Reimbursement and clinical guidance for pharmaceuticals in Sweden RePEc:spr:eujhec:v:6:y:2005:i:3:p:274-279 [Citation Analysis]	3
2006	Fixed budgets as a cost containment measure for pharmaceuticals RePEc:spr:eujhec:v:7:y:2006:i:1:p:37-45 [Citation Analysis]	3
2006	Alcohol-related mortality, drinking behavior, and business cycles RePEc:spr:eujhec:v:7:y:2006:i:3:p:212-217 [Citation Analysis]	3
2006	Tests of stationarity and cointegration of health care expenditure and gross domestic product RePEc:spr:eujhec:v:7:y:2006:i:4:p:285-289 [Citation Analysis]	3
2004	Economic growth, longevity and the epidemiological transition RePEc:spr:eujhec:v:5:y:2004:i:2:p:166-174 [Citation Analysis]	3
2011	Ageing and health care expenditure in EU-15 RePEc:spr:eujhec:v:12:y:2011:i:5:p:469-478 [Citation Analysis]	3
2006	Costs and quality of life of multiple sclerosis in Sweden RePEc:spr:eujhec:v:7:y:2006:i:2:p:75-85 [Citation Analysis]	2
2009	The quality of life of Palestinians living in chronic conflict: assessment and determinants RePEc:spr:eujhec:v:10:y:2009:i:1:p:93-101 [Citation Analysis]	2
2005	Modeling the economic burden of diseases imputable to stress at work RePEc:spr:eujhec:v:6:y:2005:i:1:p:16-23 [Citation Analysis]	2
2006	Health care and patients’ migration across Spanish regions RePEc:spr:eujhec:v:7:y:2006:i:2:p:114-116 [Citation Analysis]	2
2008	Work environment satisfaction and employee health: panel evidence from Denmark, France and Spain, 1994–2001 RePEc:spr:eujhec:v:9:y:2008:i:1:p:51-61 [Citation Analysis]	2
2006	Determinants of household health expenditure on western institutional health care RePEc:spr:eujhec:v:7:y:2006:i:3:p:195-203 [Citation Analysis]	2
2005	Estimating utility data from clinical indicators for patients with stable angina RePEc:spr:eujhec:v:6:y:2005:i:4:p:347-353 [Citation Analysis]	2
2007	A multilevel analysis on the determinants of regional health care expenditure: a note RePEc:spr:eujhec:v:8:y:2007:i:1:p:59-65 [Citation Analysis]	2
2004	Out-patient drug policy by clinical assessment rather than financial constraints? RePEc:spr:eujhec:v:5:y:2004:i:3:p:274-277 [Citation Analysis]	2
2005	A ‘new and improved’ EQ-5D valuation questionnaire? RePEc:spr:eujhec:v:6:y:2005:i:1:p:73-82 [Citation Analysis]	2
2010	On the welfare theoretic foundation of CEA: comment RePEc:spr:eujhec:v:11:y:2010:i:6:p:595-596 [Citation Analysis]	2
2006	Off-patent drugs in Italy RePEc:spr:eujhec:v:7:y:2006:i:1:p:79-83 [Citation Analysis]	2
2003	Scale of reference bias and the evolution of health RePEc:spr:eujhec:v:4:y:2003:i:3:p:176-183 [Citation Analysis]	2
2009	Factors affecting nurses’ decision to get the flu vaccine RePEc:spr:eujhec:v:10:y:2009:i:2:p:227-231 [Citation Analysis]	2
2010	Optimal savings and health spending over the life cycle RePEc:spr:eujhec:v:11:y:2010:i:4:p:355-365 [Citation Analysis]	2
2005	Spanish health benefits for services of curative care RePEc:spr:eujhec:v:6:y:2005:i:1:p:66-72 [Citation Analysis]	2
2009	Do quality-adjusted life years take account of lost income? Evidence from an Australian survey RePEc:spr:eujhec:v:10:y:2009:i:1:p:103-109 [Citation Analysis]	2
2006	Time for a common standard for cost-effectiveness in Europe? RePEc:spr:eujhec:v:7:y:2006:i:4:p:223-224 [Citation Analysis]	2
2010	In which ways do unhealthy people older than 50 exit the labour market in France? RePEc:spr:eujhec:v:11:y:2010:i:2:p:127-140 [Citation Analysis]	2
2010	A French approach to cost-effectiveness analysis? RePEc:spr:eujhec:v:11:y:2010:i:6:p:521-523 [Citation Analysis]	2
2006	Costs and quality of life of multiple sclerosis in Sweden RePEc:spr:eujhec:v:7:y:2006:i:02:p:75-85 [Citation Analysis]	2
2003	A single European currency for EQ-5D health states RePEc:spr:eujhec:v:4:y:2003:i:3:p:222-231 [Citation Analysis]	2
2004	Economic valuation of informal care RePEc:spr:eujhec:v:5:y:2004:i:1:p:36-45 [Citation Analysis]	2
2004	What reimbursement for coronary revascularization with drug-eluting stents? RePEc:spr:eujhec:v:5:y:2004:i:4:p:309-316 [Citation Analysis]	2
2003	When should decision-analytic modeling be used in the economic evaluation of health care? RePEc:spr:eujhec:v:4:y:2003:i:3:p:143-150 [Citation Analysis]	2
2005	Validating the EQ-5D with time trade off for the German population RePEc:spr:eujhec:v:6:y:2005:i:2:p:124-130 [Citation Analysis]	2
2010	The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany RePEc:spr:eujhec:v:11:y:2010:i:3:p:267-277 [Citation Analysis]	2
2005	Defining the “Health Benefit Basket” in nine European countries RePEc:spr:eujhec:v:6:y:2005:i:1:p:2-10 [Citation Analysis]	2
2008	Redistributive effects in public health care financing RePEc:spr:eujhec:v:9:y:2008:i:4:p:405-416 [Citation Analysis]	2
2010	Health insurance for the poor: impact on catastrophic and out-of-pocket health expenditures in Mexico RePEc:spr:eujhec:v:11:y:2010:i:5:p:437-447 [Citation Analysis]	2
2005	Time preference bias in time trade-off RePEc:spr:eujhec:v:6:y:2005:i:2:p:107-111 [Citation Analysis]	1
2008	Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia RePEc:spr:eujhec:v:9:y:2008:i:3:p:221-228 [Citation Analysis]	1

Citing documents used to compute impact factor 11:

Year	Title	See
2010	Adoption and Impact of Improved Groundnut Varieties on Rural Poverty: Evidence from Rural Uganda RePEc:rff:dpaper:dp-10-11-efd	[Citation Analysis]
2010	On the welfare theoretic foundation of cost-effectiveness analysis—the case when survival is not affected RePEc:spr:eujhec:v:11:y:2010:i:1:p:5-13	[Citation Analysis]
2010	Privatization of local public hospitals: effect on budget, medical service quality, and social welfare RePEc:kap:ijhcfe:v:10:y:2010:i:3:p:275-299	[Citation Analysis]
2010	ECONOMIC AND BEHAVIORAL FACTORS IN AN INDIVIDUALfS DECISION TO GET AN INFLUENZA VACCINATION IN JAPAN RePEc:osk:wpaper:1023	[Citation Analysis]
2010	Work, Risk and Health: Differences between Immigrants and Natives in Spain RePEc:iza:izadps:dp5338	[Citation Analysis]
2010	Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure RePEc:spr:eujhec:v:11:y:2010:i:1:p:95-104	[Citation Analysis]
2010	Future challenges for health economics and health technology assessment of biological drugs RePEc:spr:eujhec:v:11:y:2010:i:3:p:235-238	[Citation Analysis]
2010	Natural Experiment Evidence on the Effect of Migration on Blood Pressure and Hypertension RePEc:crm:wpaper:1024	[Citation Analysis]
2010	Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy RePEc:wly:hlthec:v:19:y:2010:i:10:p:1193-1211	[Citation Analysis]
2010	Selbstbeteiligung als Lösung für das Moral-Hazard-Problem auf dem Arzneimittelmarkt? RePEc:pra:mprapa:27425	[Citation Analysis]
2010	Sins of omission and obfuscation: IQWIGs guidelines on economic evaluation methods RePEc:wly:hlthec:v:19:y:2010:i:10:p:1132-1136	[Citation Analysis]

Cites in year: CiY